Cetuximab is effective, but more toxic than reported in the bonner trial

被引：20

作者：

Lord, H. K. ^{[1
]}

Junor, E. ^{[1
]}

Ironside, J. ^{[1
]}

机构：

[1] Edinburgh Canc Ctr, Edinburgh, Midlothian, Scotland

来源：

CLINICAL ONCOLOGY | 2008年 / 20卷 / 01期

关键词：

D O I：

10.1016/j.clon.2007.09.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：96 / 96

页数：1

共 3 条

[1] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[2] Severe cutaneous reaction during radiation therapy with concurrent cetuximab [J].

Budach, Wilfried ;

Boelke, Edwin ;

Homey, Bernhard .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (05) :514-515

[3] Mechanisms of cutaneous toxicities to EGFR inhibitors [J].

Lacouture, Mario E. .

NATURE REVIEWS CANCER, 2006, 6 (10) :803-812

← 1 →